Background: The Strategic Multi-Attribute Ranking Tool for Vaccines (SMART Vaccines) is a decision-support tool developed by the Institute of Medicine and the National Academy of Engineering (USA) to assist countries in prioritizing new vaccines. This system is based on a multi-criteria decision analysis (MCDA), which is well-established and generally accepted tool to support Health Technology Assessment (HTA) agencies in a lot of countries for setting healthcare priorities. The primary research objective of this study was to prioritize the introduction of new vaccines in Indonesia by using the framework of SMART, focusing on Pneumococcal Conjugate Vaccine (PCV), rotavirus, Human Papilloma Virus (HPV) and Japanese Encephalitis (JE) vaccines, and exploring country-specific data related to all predefined attributes for these vaccines.
Conclusions: According to the priority list of World Health Organization (WHO), PCV, rotavirus and HPV vaccines are categorized as high priority vaccines, while JE vaccine is categorized as a low priority vaccine. The results of this study confirmed that PCV, rotavirus and HPV vaccine should be more prioritized than JE.